EUVIMEDEUVIMED entdecken
Crossref

Assessment of the role of injectable hydrolyzed collagen in the treatment of knee osteoarthritis, factors predicting the therapeutic effect

Olga V. Teplyakova, Olga G. Tsvetkova

HERALD of North-Western State Medical University named after I.I. Mechnikov · 31.03.2026 · 18 (1) · 52-60

DOI: 10.17816/mechnikov699041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HERALD of North-Western State Medical University named after I.I. Mechnikov, online erschienen am 31.03.2026. Verfasst von Olga V. Teplyakova und 1 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Knee osteoarthritis is the most common condition encountered in the practice of a rheumatologist. Given the high comorbidity of patients with osteoarthritis, local injectable therapy may be chosen as a treatment strategy for such patients. One of the promising directions in the development of local injectable therapy for knee osteoarthritis is intra-articular collagen injections. AIM: Assessment of the safety and efficacy of injections of the medical device Compositron® 2 in the treatment of knee osteoarthritis, as well as a description of the phenotypic features of patients who achieved the best response to local injectable therapy for osteoarthritis. METHODS: The prospective study included 30 women with stage II osteoarthritis and a stable disease course. None of the study participants had received intra-articular injections during the previous 6 months. All patients received three intra-articular injections of Compositron® 2 on days 1, 15, and 45 of the study. The treatment efficacy was assessed using the KOOS (Knee injury and Osteoarthritis Outcome Score) scale. RESULTS: The study results demonstrated high efficacy of Compositron® 2 injections in knee osteoarthritis: in 70% of patients, the total KOOS score increased by the 6th month of follow-up. During therapy, 80% of patients reported a reduction in disease symptoms and improvement in daily activity, 73.3% reported pain reduction, 53.3% reported an increase in sports activity, and 70% reported an improvement in quality of life. A faster response to therapy was observed in patients with a high level of anxiety (HADS), without obesity, and with a high level of pain catastrophizing (PCS scale), but after a 3-month follow-up period, improvement was seen in all patient groups. None of the study participants reported adverse events or withdrew from the study. CONCLUSION: Compositron® 2 may be considered as an effective adjuvant agent for the treatment of knee osteoarthritis.

Zitieren

APA

Teplyakova, O. V., & Tsvetkova, O. G. (2026). Assessment of the role of injectable hydrolyzed collagen in the treatment of knee osteoarthritis, factors predicting the therapeutic effect. HERALD of North-Western State Medical University named after I.I. Mechnikov, 18(1), 52-60. https://doi.org/10.17816/mechnikov699041

Vancouver

Teplyakova OV, Tsvetkova OG. Assessment of the role of injectable hydrolyzed collagen in the treatment of knee osteoarthritis, factors predicting the therapeutic effect. HERALD of North-Western State Medical University named after I.I. Mechnikov. 2026;18(1):52-60. doi:10.17816/mechnikov699041

BibTeX
@article{Teplyakova2026,
  author = {Teplyakova, Olga V. and Tsvetkova, Olga G.},
  title = {Assessment of the role of injectable hydrolyzed collagen in the treatment of knee osteoarthritis, factors predicting the therapeutic effect},
  journal = {HERALD of North-Western State Medical University named after I.I. Mechnikov},
  year = {2026},
  volume = {18},
  number = {1},
  pages = {52--60},
  doi = {10.17816/mechnikov699041}
}
Kostenlos starten →